Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Healthicare vs Vaylen

Healthicare costs $5 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Healthicare logo

Healthicare

7.4
★★★★☆3.7/5

Best for: moving between compounded and brand without changing seller

Visit Healthicare →
VS
Vaylen logo

Vaylen

8.2
★★★★☆4.1/5

Best for: bloodwork inside the $179/month rather than billed on top

Visit Vaylen →

If you are choosing between Healthicare and Vaylen, the first difference is cost: Healthicare is $5 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Vaylen leads our six-part score, 8.2 to 7.4.

Healthicare vs Vaylen price

Healthicare is the cheaper way in: $174 a month against $179 a month at Vaylen. That is $5 less each month (3% lower), or about $60 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Healthicare ($174 a month vs $179 a month); tirzepatide is cheaper at Vaylen ($239 a month vs $264 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Healthicare prices compounded injections, an oral option and brand-name pens, while Vaylen prices compounded injections and brand-name pens.

Where each one treats patients

Healthicare does not publish where it ships, and Vaylen lists 50 states.

Pricing

Healthicare

Compounded semaglutide (billed monthly)Compounded
$174/mo
semaglutide

$174/mo billed monthly; $147.90/mo on the 3-month plan ($443.70 billed every 3 months)

Compounded tirzepatide (billed monthly)Compounded
$264/mo
tirzepatide

$264/mo billed monthly; $224.40/mo on the 3-month plan ($673.20 billed every 3 months)

Semaglutide Oral Dropsoral
$250$150/mo
Save 40% right now
semaglutide

$149.99 first month ($100 off), $249.99/mo after

Brand Ozempic / Wegovy / Mounjaro / ZepboundBrand-name
$1300$1200/mo
Save 8% right now
semaglutide

From $1,299.99/mo; first month From $1,199.99 ($100 off)

Vaylen

Compounded SemaglutideCompounded
$179/mo
semaglutide
Compounded TirzepatideCompounded
$239/mo
tirzepatide
Compounded Oral GLP-1Compounded
$259/mo
semaglutide
OzempicBrand-name
$997/mo
semaglutide
ZepboundBrand-name
$1086/mo
tirzepatide

What each price covers

Both prices cover the clinician visit, the medication itself, shipping and coaching.

Vaylen's price also covers lab work, which Healthicare does not claim.

Healthicare is silent on lab work.

Healthicare

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Vaylen

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

In the price

Coaching

In the price

Where each one scores higher

Overall, Vaylen scores 8.2 and Healthicare 7.4 out of 10.

Healthicare is stronger on user experience (8.0 vs 7.5).

Vaylen is stronger on trust & safety (8.5 vs 6.5), accessibility (10.0 vs 5.0) and support (10.0 vs 8.5).

Value and effectiveness are within half a point.

How we score

Healthicare

7.4/10

Overall

Vaylen

8.2/10

Value25%

5.4A
vs
B
5.3

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

6.5A
vs
B
8.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

8.5A
vs
B
10.0

FDA warning letters

Neither Healthicare nor Vaylen has an FDA warning letter on record with us.

Features & Coverage

FeatureHealthicareVaylen
Starting Price✓$174/mo$179/mo
Features8 features8 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Healthicare

Two names Healthicare puts in public that most of this segment keeps quiet: Beluga Health, its clinical partner, and Jungle Jim's Pharmacy of Fairfield, OH, which dispenses. Coverage on this GLP-1 telehealth platform reaches 44 states. Compounded semaglutide opens at $147.90/mo, compounded tirzepatide at $224.40/mo. One account also reaches the full brand menu, Zepbound, Mounjaro, Wegovy, and Ozempic.

Read our full Healthicare review →

About Vaylen

Vaylen is a pure GLP-1 specialist: compounded semaglutide at $179/mo, compounded tirzepatide at $239/mo, a compounded oral GLP-1 at $259/mo, and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified, with licensed clinicians in all 50 states.

Read our full Vaylen review →

Pros & Cons

Healthicare

What we like

  • Semaglutide costs $174 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $264 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • We found no FDA warning letters issued to Healthicare
  • Offers both oral and injectable options, so the format is your choice

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Vaylen

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $239 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping, lab work and coaching
  • Serves all 50 states
  • We found no FDA warning letters issued to Vaylen
  • Baseline bloodwork is required before a prescription

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Vaylen

Vaylen wins this one, 8.2 to 7.4, above all for bloodwork inside the $179/month rather than billed on top. Healthicare undercuts it by $5 a month, so if the monthly bill is what decides it, Healthicare is the pick. Healthicare fits better if moving between compounded and brand without changing seller is your priority.

Choose Healthicare if…

You want moving between compounded and brand without changing seller and an opening price near $174 a month.

Choose Vaylen if…

You want bloodwork inside the $179/month rather than billed on top and an opening price near $179 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

Healthicare vs Vaylen: FAQ

Healthicare. It starts at $174 a month; Vaylen starts at $179 a month, $5 more per month.
Yes, both sell semaglutide and tirzepatide.
Healthicare does not publish where it ships; Vaylen lists 50 states. Confirm your state before paying.
Both include the clinician visit, the medication itself, shipping and coaching. Only Vaylen includes lab work.
Healthicare has none. Vaylen has none.
No. Neither Healthicare nor Vaylen pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.